These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 7724702)

  • 1. Inter-individual diversity and intra-individual stability of amphetamine-induced sensitization of frequency-modulated 50-kHz vocalization in Sprague-Dawley rats.
    Taracha E; Hamed A; Krząścik P; Lehner M; Skórzewska A; Płaźnik A; Chrapusta SJ
    Psychopharmacology (Berl); 2012 Aug; 222(4):619-32. PubMed ID: 22354555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical View on the Usage of Ribavirin in Already Existing Psychostimulant-Use Disorder.
    Petković B; Kesić S; Pešić V
    Curr Pharm Des; 2020; 26(4):466-484. PubMed ID: 31939725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contingent tolerance to amphetamine hypophagia: new insights into the role of environmental context in the expression of stereotypy.
    Wolgin DL
    Neurosci Biobehav Rev; 2000 May; 24(3):279-94. PubMed ID: 10781692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Modification of the behavioral effects of drugs after repeated administration--special reference to the reverse tolerance of amphetamines].
    Tadokoro S; Kuribara H
    Nihon Yakurigaku Zasshi; 1990 May; 95(5):229-38. PubMed ID: 2191909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and reversal of sensitization to amphetamine-induced hypophagia: role of temporal, pharmacological, and behavioral variables.
    Wolgin DL
    Psychopharmacology (Berl); 1995 Jan; 117(1):49-54. PubMed ID: 7724702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of sensitization of stereotypy on the acquisition and retention of tolerance to amphetamine hypophagia.
    Wolgin DL; Hughes KM
    Psychopharmacology (Berl); 1996 Aug; 126(3):219-25. PubMed ID: 8876021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experiential constraints on the development of tolerance to amphetamine hypophagia following sensitization of stereotypy: instrumental contingencies regulate the expression of sensitization.
    Hughes KM; Popi L; Wolgin DL
    Psychopharmacology (Berl); 1998 Dec; 140(4):445-9. PubMed ID: 9888620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of prior sensitization of stereotypy on the development of tolerance to amphetamine-induced hypophagia.
    Wolgin DL; Kinney GG
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1232-41. PubMed ID: 1527726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term retention of tolerance to amphetamine hypophagia following cessation of drug injections and feeding tests.
    Wolgin DL; Hughes KM
    Pharmacol Biochem Behav; 2001; 70(2-3):367-73. PubMed ID: 11701209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of behavioral and pharmacological variables in the loss of tolerance to amphetamine hypophagia.
    Wolgin DL; Hughes KM
    Psychopharmacology (Berl); 1997 Aug; 132(4):342-9. PubMed ID: 9298511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent tolerance to some aspects of amphetamine stereotypy with long-term treatment.
    Rebec GV; Segal DS
    Pharmacol Biochem Behav; 1980 Dec; 13(6):793-7. PubMed ID: 7193874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent versus continuous stimulation: effect of time interval on the development of sensitization or tolerance.
    Post RM
    Life Sci; 1980 Apr; 26(16):1275-82. PubMed ID: 6991841
    [No Abstract]   [Full Text] [Related]  

  • 13. An analysis of behavioural mechanisms involved in the acquisition of amphetamine anorectic tolerance.
    Demellweek C; Goudie AJ
    Psychopharmacology (Berl); 1983; 79(1):58-66. PubMed ID: 6403966
    [No Abstract]   [Full Text] [Related]  

  • 14. Behavioral variables affecting the development of amphetamine tolerance.
    Schuster CR; Dockens WS; Woods JH
    Psychopharmacologia; 1966; 9(2):170-82. PubMed ID: 5983915
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.